The Carlyle Group completed the $700m investment in MAK-SYSTEM.

The Carlyle Group completed the $700m investment in MAK-SYSTEM, a provider of software solutions supporting the entire blood chain management process. "We are delighted at the opportunity to be working with Carlyle, one of the most predominant investors in the healthcare space. This partnership will enable us to better serve our clients and rapidly extend our footprint with numerous innovations," Simon Kiskovski, MAK Founder.